|
Development of a small molecule activator of integrin cell adhesion to enhance therapeutic responses to checkpoint blockade in cancer
|
1R41CA203456-01A1
|
$313,705
|
$313,705
|
MARATHI, UPENDRA
|
7 HILLS PHARMA, LLC
|
|
Validation and humanization of a PET imaging agent that targets PD-L1.
|
1R43CA203138-01A1
|
$300,000
|
$300,000
|
GOSTISSA, MONICA
|
AGENUS, INC.
|
|
Development of immuno-PET agents for the selective imaging of CD8 T cells
|
1R43CA210714-01A1
|
$300,000
|
$300,000
|
GOSTISSA, MONICA
|
AGENUS, INC.
|
|
Novel Strategies for Precision T-cell Therapies
|
1R01CA198095-01A1
|
$520,564
|
$260,282
|
ALMO, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
3P30CA013330-44S1
|
$199,871
|
$3,997
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
3P30CA013330-44S2
|
$199,989
|
$4,000
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
3P30CA013330-44S3
|
$500,000
|
$10,000
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
5P30CA013330-44
|
$3,746,138
|
$74,923
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
A CD47-blocking oncolytic vaccinia virus for cancer therapy
|
1F30CA203270-01
|
$43,576
|
$43,576
|
CAO, FELICIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
REGULATION OF UVEAL MELANOMA CELL FATE BY THE PKC PATHWAY VIA MITF
|
5R01CA193321-02
|
$362,569
|
$362,569
|
MITSIADES, NICHOLAS
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S1
|
$118,016
|
$2,360
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S2
|
$170,897
|
$3,418
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S3
|
$118,875
|
$2,378
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S4
|
$499,947
|
$9,999
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S5
|
$134,220
|
$2,684
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-10
|
$3,253,119
|
$65,062
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
CpG-ODN Coated Hollow Gold Nanoshells for Photothermal Therapy
|
4R01CA172836-04
|
$342,894
|
$171,447
|
FOSTER, AARON
|
BELLICUM PHARMACEUTICALS, INC.
|
|
Cbx-3/HP-1gamma deficiency confers anti-tumor immunity
|
1R21CA198263-01A1
|
$188,138
|
$188,138
|
THAI, TO-HA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Development of a novel cell-based immune therapy using Nanoparticles and natural IgM-producing phagocytic B cells
|
1R21CA205415-01
|
$241,061
|
$241,061
|
ZHONG, XUEMEI
|
BOSTON MEDICAL CENTER
|
|
Molecular connections among UV exposure, red hair, nevi and melanoma
|
1R01CA193913-01A1
|
$375,227
|
$375,227
|
CUI, RUTAO
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Why red-haired individuals are so prone to developing melanoma
|
5R01CA196896-02
|
$374,464
|
$374,464
|
CUI, RUTAO
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Elucidating the Regulation and Function of the NF1 tumor suppressor
|
2R01CA111754-11A1
|
$316,635
|
$158,318
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Functional Analysis of Galectin-1 Ligands in Melanoma Progression
|
4R01CA173610-04
|
$361,558
|
$361,558
|
DIMITROFF, CHARLES
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
|
1R01CA208756-01
|
$518,165
|
$259,083
|
HACOHEN, NIR
|
BROAD INSTITUTE, INC.
|
|
Psoralens and melanoma
|
5R21CA198216-02
|
$210,422
|
$210,422
|
CHO, EUNYOUNG
|
BROWN UNIVERSITY
|
|
Nanosystems Biology Cancer Center
|
5U54CA199090-02
|
$2,446,594
|
$660,580
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
PHIP as a Biomarker of Triple-Negative Melanoma
|
5R01CA175768-03
|
$424,835
|
$424,835
|
KASHANI-SABET, MOHAMMED
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
|
Targeting the developmental pathways Notch and ERBB for melanoma therapy
|
5R01CA177652-03
|
$348,616
|
$348,616
|
BEDOGNI, BARBARA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Targeting an MT1-MMP/MMP2 axis in melanoma by a novel MT1-MMP/MMP2 inhibitor
|
5R21CA187695-02
|
$174,147
|
$174,147
|
BEDOGNI, BARBARA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Bone Marrow MSCs/Pericytes: Gatekeepers Controlling Skeletal Metastasis.
|
4R01CA163562-05
|
$325,775
|
$162,888
|
CAPLAN, ARNOLD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S1
|
$20,833
|
$625
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S2
|
$60,000
|
$1,800
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S3
|
$118,406
|
$3,552
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S4
|
$200,000
|
$6,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
4P30CA043703-26
|
$4,895,515
|
$146,865
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
5U10CA180853-03
|
$1,033,213
|
$25,830
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
The Development of Novel Mechanistically-based APE/Ref-1 Redox Inhibitors
|
5K08CA179084-03
|
$113,788
|
$56,894
|
YANG, SUN
|
CHAPMAN UNIVERSITY
|
|
Defining driver tumor-suppressors for melanoma using the zebrafish
|
1K99CA201465-01
|
$171,990
|
$171,990
|
ABLAIN, JULIEN
|
CHILDREN'S HOSPITAL CORPORATION
|
|
Immunology of human malignant melanoma initiating cells
|
4R01CA158467-05
|
$364,127
|
$364,127
|
FRANK, MARKUS
|
CHILDREN'S HOSPITAL CORPORATION
|
|
Defining oncogenic capacities of PAK7 mutations in human cancer
|
5R21CA184656-02
|
$192,488
|
$48,122
|
HANSEN, STEEN
|
CHILDREN'S HOSPITAL CORPORATION
|
|
Cancer biology in the zebrafish
|
4R01CA103846-14
|
$373,081
|
$373,081
|
ZON, LEONARD
|
CHILDREN'S HOSPITAL CORPORATION
|
|
Effect of different MRgHIFU approaches on anti-tumor responses
|
1R03CA201918-01
|
$78,000
|
$78,000
|
JANSSEN, EDITH
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Improving adoptive cell therapy by enhancing T cell longevity
|
5R21CA188767-02
|
$172,369
|
$172,369
|
DIAZ-MONTERO, CLAUDIA
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Integrative Cancer Genomics: Drivers, Pathways and Drugs
|
4R01CA164729-05
|
$464,984
|
$69,748
|
PE'ER, DANA
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Replication fork remodeling and genomic stability
|
1R01CA197774-01A1
|
$343,830
|
$171,915
|
CICCIA, ALBERTO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S1
|
$120,000
|
$1,200
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S2
|
$60,000
|
$600
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S3
|
$121,873
|
$1,219
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S4
|
$150,866
|
$1,509
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S5
|
$199,541
|
$1,995
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
Total relevant funding to Melanoma for this search: $142,932,957
|